生酮饮食治疗难治性抑郁症:一项随机临床试验
该随机临床试验纳入88名难治性抑郁症成人,比较6周生酮饮食与对照饮食的疗效。
要点
- 第12周组间差异未达统计学显著(-1.85,95%CI -4.04至0.33,P=0.10)。
- 两组均无严重不良事件,但生酮饮食的临床相关性尚不明确。
核心结论
- 在难治性抑郁症成人中,6周生酮饮食较匹配的对照饮食在第6周显示出抗抑郁获益,但效应量中等且次要分析未显现,临床相关性不确定。
研究设计与样本
- 随机临床试验,2024年2月22日至6月15日在英国开展,纳入88名18至65岁、PHQ-9≥15的难治性抑郁症患者,按1:1随机分配至6周生酮饮食组或对照饮食组,末次随访至12周。
主要发现
- 第6周PHQ-9评分较基线平均变化:生酮组-10.5(SD 7.0),对照组-8.3(SD 5.1)。
- 第12周组间PHQ-9评分差异为-1.85(95%CI -4.04至0.33;P=0.10;Cohen d=-0.58;95%CI -1.26至0.10)。
- 次要结局(包括12周PHQ-9评分、抑郁缓解、焦虑、快感缺失、认知损害、生活质量和功能结局)在两组间无差异。
- 无严重不良事件发生。
临床怎么用
- 对于难治性抑郁症成人,生酮饮食可作为短期辅助干预的候选方案,但需权衡效应量中等且临床相关性不确定的证据。
- 实施生酮饮食需提供每周个体化营养支持,并监测不良事件。
局限性
- 样本量较小(88例),随访时间较短(12周),且为单国研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Preclinical evidence and case reports suggest potential therapeutic benefits of ketogenic diets (KDs) in the treatment of depression, but evidence from well-controlled randomized clinical trials (RCTs) is lacking. OBJECTIVE: To assess the efficacy of a KD compared with a control diet in adults with treatment-resistant depression (TRD). DESIGN, SETTING, AND PARTICIPANTS: This RCT was conducted between February 22 and June 15, 2024. Participants aged 18 to 65 years with TRD and a score of 15 or greater on the 9-item Patient Health Questionnaire (PHQ-9) from across the UK were included. INTERVENTION: Participants were randomized 1:1 to one of two 6-week dietary interventions: (1) KD of prepared foods providing less than 30 g of carbohydrates per day with weekly individual dietetic support or (2) a control (phytochemical [phyto]) diet with vouchers to purchase 1 extra serving of vegetables or fruit and replace saturated fats with unsaturated fats, with equal dietetic support. The last follow-up was at 12 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was the between-group difference in change in PHQ-9 score from baseline to week 6. Secondary outcomes included PHQ-9 score at 12 weeks, depression remission, anxiety, anhedonia, cognitive impairment, quality of life, and functional outcomes. RESULTS: The study included 88 participants (mean [SD] age, 42.1 [13.1] years; 61 women [69%]): 44 in the KD group and 44 in the phyto diet group. Depression severity decreased markedly in both groups; the mean (SD) change in PHQ-9 score from baseline to week 6 was -10.5 (7.0) in the KD group and -8.3 (5.1) in the phyto group. The mean between-group differences in PHQ-9 score at 6 and 12 weeks were -2.18 (95% CI, -4.33 to -0.03; P = .05; Cohen d, -0.68; 95% CI -1.35 to -0.01) and -1.85 (95% CI, -4.04 to 0.33; P = .10; Cohen d, -0.58; 95% CI, -1.26 to 0.10), respectively. There were no differences in secondary outcomes between the KD and phyto groups. No serious adverse events occurred. CONCLUSIONS AND RELEVANCE: In this RCT, a KD had antidepressant benefits compared with a well-matched control diet at 6 weeks. However, the clinical relevance is uncertain, as the mean effect size compared with the control was modest and not evident in secondary analyses. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06091163.
引用
- Gao M, Kirk M, Knight H, et al. A Ketogenic Diet for Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 41637092. doi:10.1001/jamapsychiatry.2025.4431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。